MENU
CMPX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Compass Therapeutics (CMPX) Ownership - Who owns Compass Therapeutics?
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies... Show more
Profile
Industry
N/A
Address
80 Guest Street
Phone
+1 617 500-8099
Employees
32
Web
https://www.compasstherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
290.39M
P/E Ratio
N/A
Total Cash
112.64M
Projected Growth
N/A
Total Debt
6.38M
Revenue
850K
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash/Share
0.81
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
CMPX
Capitalization
290M
P/E Ratio
N/A
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash
113M
Total Cash/Share
0.81
Total Debt
6.38M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
850K
ROE
N/A
Book Value
110M
P/B Ratio
2.63
Cash Flow
N/A
Earnings
-0.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
14K
Current Ratio
8.33
Current Revenue Per Employee
26562.50
Dividends Per Share - Security
N/A
EBITDA
-60.17M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-37.75
Shares Held By Institutions
201M
Shares Outstanding - Current
138M
Total Liabilities
21.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
42.069
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
80 Guest Street
Phone
+1 617 500-8099
Employees
32
Web
https://www.compasstherapeutics.com